Cambridge Investment Research Advisors »

Cardlytics shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Cardlytics (CDLX) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Cardlytics

Tip: Access up to 7 years of quarterly data

All positions including Cardlytics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardlytics by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $27k 26k 1.05

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Microsoft Corp Com (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Alphabet Inc Cap Stk Cl C (GOOG)
SPDR Gold Tr Gold Shs (GLD)

View all positions for Cambridge Investment Research Advisors

Top funds holding Cardlytics

CAS Investment Partners
Vanguard Group
Vanguard Capital Management
683 Capital Management
KPS Global Asset Management UK
Worldly Partners Management
BlackRock
Susquehanna International
Rbf Capital
Geode Capital Management
Quinn Opportunity Partners
LPL Financial
Vanguard Fiduciary Trust
Citadel Advisors
GSA Capital Partners

View all funds holding Cardlytics